NitricBio is a specialty pharmaceutical company developing drug delivery technologies for the dermatology and podiatry markets.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Bristol
State: Pennsylvania
Zip:
Country: United States
NitricBio is a mid-stage specialty pharmaceutical company focused on the dermatology and podiatry markets, with two unique drug delivery technologies. The first technology involves the development and commercialization of topical nitric oxide gas. Nitric oxide has both direct and regulatory actions with known anti-infective and anti-inflammatory properties. The company&s;s current focus is on the development of a treatment for moderate-to-severe tinea pedis (athlete&s;s foot), which is currently in late Phase 2 clinical trials.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2006 | Series A | 3 | $14M |
Cardinal Health NewSpring Quaker BioVentures Cardinal Health NewSpring Quaker BioVentures |
4/2009 | Debt Financing | $1.7M | 7/2010 | Debt Financing | $1.8M | 1/2012 | Debt Financing | $1M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|